Dana Price, MD

I chose to pursue a career in pediatric medicine because I wanted to help improve the quality of children’s lives. Pediatric neurology proved to be a challenging and intriguing way to do this. I specialize in treating epilepsy, and by helping to control seizures, I have a significant impact on the lives of children and their families.

As a mother, I deeply appreciate the trust families place in me to care for their child. It is rewarding to form a bond with them as we work together to improve their child’s quality of life.

At the Comprehensive Epilepsy Center, I treat many types of epilepsy, including rare genetic epilepsy syndromes. These include CDKL5 deficiency disorder, Angelman syndrome, Dup15q syndrome, epilepsy associated with abnormalities in the KCNQ2 gene, and Lennox-Gastaut syndrome. I am the director of NYU Langone’s Angelman Syndrome Clinic and the CDKL5 Deficiency Disorder Center of Excellence at the Comprehensive Epilepsy Center.

My patients benefit from the comprehensive care I provide. I use electroencephalograms (EEGs), which record brain activity to diagnose and manage epilepsy. Children with epilepsy have access to genetic testing, clinical trials, and the state-of-the-art Hassenfeld Children’s Hospital at NYU Langone.

I collaborate with expert multidisciplinary teams, which include dietitians, geneticists, neuroradiologists, neuropsychologists, and neurosurgeons, to offer cutting-edge treatments and surgical interventions.

Epilepsy is a rapidly evolving field, and I partner with researchers around the world to study rare genetic epilepsy syndromes. I am currently involved in research and clinical trials on CDKL5 deficiency disorder, Dravet syndrome, and autism.

I am also an active member of the American Academy of Neurology and the American Epilepsy Society.